These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38061803)

  • 1. The potential role of protein disulfide isomerases (PDIs) during parasitic infections: a focus on Leishmania spp.
    Dousti M; Hosseinpour M; D Ghasemi N; Mirfakhraee H; Rajabi SK; Rashidi S; Hatam G
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 38061803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis.
    Hong BX; Soong L
    Parasitol Res; 2008 Feb; 102(3):437-46. PubMed ID: 18058133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis.
    Varela-M RE; Ochoa R; Muskus CE; Muro A; Mollinedo F
    Parasit Vectors; 2017 Oct; 10(1):458. PubMed ID: 29017516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlighting the interplay of microRNAs from
    Rashidi S; Mansouri R; Ali-Hassanzadeh M; Ghani E; Barazesh A; Karimazar M; Nguewa P; Carrera Silva EA
    Parasitology; 2021 Oct; 148(12):1434-1446. PubMed ID: 34218829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite.
    Cabello-Donayre M; Orrego LM; Herráez E; Vargas P; Martínez-García M; Campos-Salinas J; Pérez-Victoria I; Vicente B; Marín JJG; Pérez-Victoria JM
    Cell Mol Life Sci; 2020 May; 77(9):1827-1845. PubMed ID: 31372684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The most prominent modulated Annexins during parasitic infections.
    Rashidi S; Mansouri R; Ali-Hassanzadeh M; Muro A; Nguewa P; Manzano-Román R
    Acta Trop; 2023 Jul; 243():106942. PubMed ID: 37172709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets.
    Kumari D; Mahajan S; Kour P; Singh K
    Life Sci; 2022 Oct; 306():120829. PubMed ID: 35872004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics advances in the study of Leishmania parasites and leishmaniasis.
    de Jesus JB; Mesquita-Rodrigues C; Cuervo P
    Subcell Biochem; 2014; 74():323-49. PubMed ID: 24264252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Leishmania parasites through proteomics and implications for the clinic.
    Sundar S; Singh B
    Expert Rev Proteomics; 2018 May; 15(5):371-390. PubMed ID: 29717934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDEL Receptor 1 Contributes to Cell Surface Association of Protein Disulfide Isomerases.
    Bartels AK; Göttert S; Desel C; Schäfer M; Krossa S; Scheidig AJ; Grötzinger J; Lorenzen I
    Cell Physiol Biochem; 2019; 52(4):850-868. PubMed ID: 30958660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of genes encoding cell surface and secreted proteins that are essential for in vitro growth and infection in Leishmania donovani.
    Roberts AJ; Ong HB; Clare S; Brandt C; Harcourt K; Franssen SU; Cotton JA; Müller-Sienerth N; Wright GJ
    PLoS Pathog; 2022 Feb; 18(2):e1010364. PubMed ID: 35202447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future.
    Dinc R
    Korean J Parasitol; 2022 Dec; 60(6):379-391. PubMed ID: 36588414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially modulated proteins associated with Leishmaniasis-a systematic review of in-vivo and in-vitro studies.
    Ranjan R; Das P; Vijayakumar S
    Mol Biol Rep; 2020 Nov; 47(11):9159-9178. PubMed ID: 33113081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.
    Bandi C; Mendoza-Roldan JA; Otranto D; Alvaro A; Louzada-Flores VN; Pajoro M; Varotto-Boccazzi I; Brilli M; Manenti A; Montomoli E; Zuccotti G; Epis S
    Parasit Vectors; 2023 Jan; 16(1):35. PubMed ID: 36703216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications.
    Andreu CI; Woehlbier U; Torres M; Hetz C
    FEBS Lett; 2012 Aug; 586(18):2826-34. PubMed ID: 22828277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
    Chang KP; Reed SG; McGwire BS; Soong L
    Acta Trop; 2003 Mar; 85(3):375-90. PubMed ID: 12659975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
    Jaiswal AK; Khare P; Joshi S; Kushawaha PK; Sundar S; Dube A
    PLoS One; 2014; 9(9):e108556. PubMed ID: 25268700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.